Screening for Hypoglycemia in Exclusively Breastfed High-risk Neonates

Princy Singh1, Amit Upadhyay, Vishnubhatla Sreenivas

  • 1Department of Pediatrics, LLRM Medical College, Meerut, UP; and *Department of Biostatistics, AIIMS, New Delhi; India. Correspondence to: Dr Amit Upadhyay, Department of Pediatrics, LLRM Medical College, Meerut, India. au.llrm@gmail.com.

Indian Pediatrics
|July 2, 2017
PubMed

Insights

Nearly 30% of healthy, high-risk newborns receiving exclusive breastfeeding developed hypoglycemia within 48 hours. Low birth weight, preterm birth, and male gender were identified as significant risk factors for this condition.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Endocrinology

Background:

  • Neonatal hypoglycemia is a common concern, particularly in high-risk infants.
  • Early detection and management are crucial to prevent adverse neurodevelopmental outcomes.

Purpose of the Study:

  • To investigate the incidence of hypoglycemia in exclusively breastfed, high-risk newborns.
  • To identify risk factors associated with hypoglycemia development in this population.

Main Methods:

  • An observational study involving 407 exclusively breastfed, high-risk newborns (including low birth weight, late preterm, small/large-for-gestation, and infants of diabetic mothers).
  • Newborns were monitored in postnatal wards without neonatal intensive care unit admission.
  • Hypoglycemia was defined as blood glucose ≤46 mg/dL (2.6 mmol/L) and monitored for the first 48 hours of life.

Main Results:

  • 27% of screened newborns experienced hypoglycemia within the first 48 hours.
  • Hypoglycemia occurred more frequently in the first 2 hours of life compared to the subsequent 48 hours.
  • Low birth weight, preterm gestation, and male gender were significantly associated with an increased risk of hypoglycemia.

Conclusions:

  • Healthy, high-risk newborns who are exclusively breastfed require close monitoring for hypoglycemia, especially within the first 24 hours of life.
  • Understanding risk factors can guide proactive management strategies to prevent hypoglycemia in vulnerable newborns.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
423